MedTrace Logo

Sleep Disturbances and Biomarkers of Sarcopenic OBesity

NCT03175601 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2017-06-06

No results posted yet for this study

Summary

The general objective of this study is to identify biomarkers of sleep quality, sarcopenia, insulin resistance, oxidative stress and inflammation associated with prefrailty in middle-aged and elderly obese subjects through the integrated study of sleep patterns, functional cardiovascular testing, olfactory function and circulating molecules.

Results from the SleSOB study will contribute to identify molecular and functional determinants of prefrailty, to allow early targeted interventions and will have important implications for empowerment of elderly citizens to self-management of preventive measures and healthy lifestyle.

Conditions

  • Sarcopenic Obesity

Sponsors & Collaborators

  • Niguarda Hospital

    collaborator OTHER

  • Istituto di Fisiologia Clinica CNR

    lead OTHER

Principal Investigators

  • Maria Giovanna Trivella, MD · Istituto di Fisiologia Clinica CNR

  • Jonica Campolo, MSc · Istituto di Fisiologia Clinica CNR

Eligibility

Min Age
55 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-30
Primary Completion
2018-05-31
Completion
2018-07-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03175601 on ClinicalTrials.gov